Inhibition of prostate cancer growth by solanine requires the suppression of cell cycle proteins and the activation of ROS/P38 signaling pathway-Reference-Cited by-同舟云学术

Inhibition of prostate cancer growth by solanine requires the suppression of cell cycle proteins and the activation of ROS/P38 signaling pathway

Author:

Pan Bin¹,Zhong Weifeng²,Deng Zhihai³,Lai Caiyong¹,Chu Jing⁴,Jiao Genlong⁵,Liu Junfeng⁶,Zhou Qizhao⁷

Affiliation:

1. Department of UrologyThe First Affiliated Hospital of Jinan University Guangzhou China

2. Sun Yat‐sen Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine Guangzhou China

3. Department of UrologyGao Zhou People's Hospital Gaozhou China

4. Department of UrologyZhuhai People's Hospital Zhuhai China

5. Department of SurgeryThe First Affiliated Hospital of Jinan University Guangzhou China

6. Department of UrologyInner Mongolia People's Hospital Hohhot China

7. Department of UrologyThe Third Affiliated Hospital of Southern Medical University Guangzhou China

Funder

Natural Science Foundation of Guangdong Province, China

Medical Scientific Research Foundation of Guangdong Province, China

Guangzhou Medicine and Health Science and Technology Project

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

Reference43 articles.

4. Neoadjuvant Therapy for Prostate Cancer: An Oncologist's Perspective;Kent E. C.;Rev. Urol.,2003

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献